| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.5 |